Fortress Biotech, Inc.
Fortress Biotech, Inc. (FBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FBIO · as of Jun 9, 2026
Key Statistics
Explore Fortress Biotech, Inc. Data
fbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The FBIO analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +75.44% upside from the current price of $2.85.
Competitors & Peers
fbio competitorsFBIO
ADAG
CRVO
GANX
IMUX
NTRBStock Performance
Full HistoryAbout Fortress Biotech, Inc.
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently of…
what is fortress biotech, inc. · fbio stock overview · fortress biotech, inc. company profile · who is fortress biotech, inc. ceo · fbio NASDAQ · fortress biotech, inc. headquarters · fortress biotech, inc. business segments
About Stock Overview & Key Data
Fortress Biotech, Inc. (FBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 17, 2011. As of the latest trading session, FBIO stock price is $2.85, with a market capitalization of $94.7M. The stock has returned +33.80% over the past 12 months and -22.13% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Fortress Biotech, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Fortress Biotech, Inc. reported revenue of $63.3M and net income of $6.8M. For detailed data — including Fortress Biotech, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fortress Biotech, Inc. (FBIO) stock price is $2.85. The stock is traded on NASDAQ under the ticker symbol FBIO. The 52-week range is $1.70 – $4.53.